Literature DB >> 25085355

Silenced B-cell receptor response to autoantigen in a poor-prognostic subset of chronic lymphocytic leukemia.

Ann-Charlotte Bergh1, Chamilly Evaldsson1, Lone Bredo Pedersen2, Christian Geisler2, Kostas Stamatopoulos3, Richard Rosenquist4, Anders Rosén5.   

Abstract

Chronic lymphocytic leukemia B cells express auto/xeno antigen-reactive antibodies that bind to self-epitopes and resemble natural IgM antibodies in their repertoire. One of the antigenic structures recognized is oxidation-induced malonedialdehyde that is present on low-density lipoprotein, apoptotic blebs, and on certain microbes. The poor-prognostic stereotyped subset #1 (Clan I IGHV genes-IGKV1(D)-39) express IgM B-cell receptors that bind oxidized low-density lipoprotein. In this study, we have used for the first time this authentic cognate antigen for analysis of downstream B-cell receptor-signal transduction events, since it is more faithful to B-cell physiology than anti-IgM. Multivalent oxidized low-density lipoprotein showed specific binding to subset #1 IgM/IgD B-cell receptors, whereas native low-density lipoprotein did not. The antigen binding induced prompt receptor clustering followed by internalization. However, the receptor-signal transduction was silenced, revealing no Ca(2+) mobilization or cell-cycle entry, while phosphorylated extracellular-regulated kinase 1/2 basal levels were high and could not be elevated further by oxidized low-density lipoprotein. Interestingly, B-cell receptor responsiveness was recovered after 48-h culture in the absence of antigen in half of the cases. Toll-like receptor 9-ligand was found to breach the B-cell receptor-signaling incompetence in 5 of 12 cases pointing to intra-subset heterogeneity. Altogether, this study supports B-cell receptor unresponsiveness to cognate self-antigen on its own in poor-prognostic subset #1 chronic lymphocytic leukemia, indicating that these cells proliferate by other mechanisms that may override B-cell receptor silencing brought about in a context of self-tolerance/anergy. These novel findings have implications for the understanding of chronic lymphocytic leukemia pathobiology and therapy. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25085355      PMCID: PMC4222481          DOI: 10.3324/haematol.2014.106054

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  49 in total

Review 1.  Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion.

Authors:  Nicole Baumgarth; James W Tung; Leonore A Herzenberg
Journal:  Springer Semin Immunopathol       Date:  2005-01-05

2.  Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status.

Authors:  C Ian Mockridge; Kathleen N Potter; Isla Wheatley; Louise A Neville; Graham Packham; Freda K Stevenson
Journal:  Blood       Date:  2007-01-25       Impact factor: 22.113

3.  A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies.

Authors:  Anna Lanemo Myhrinder; Eva Hellqvist; Ekaterina Sidorova; Anita Söderberg; Helen Baxendale; Charlotte Dahle; Kerstin Willander; Gerard Tobin; Eva Bäckman; Ola Söderberg; Richard Rosenquist; Sohvi Hörkkö; Anders Rosén
Journal:  Blood       Date:  2008-01-25       Impact factor: 22.113

4.  Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.

Authors:  Ilaria Del Giudice; Sabina Chiaretti; Simona Santangelo; Simona Tavolaro; Nadia Peragine; Marilisa Marinelli; Caterina Ilari; Sara Raponi; Monica Messina; Mauro Nanni; Francesca Romana Mauro; Alfonso Piciocchi; Katia Bontempi; Davide Rossi; Gianluca Gaidano; Anna Guarini; Robin Foà
Journal:  Am J Hematol       Date:  2014-01       Impact factor: 10.047

Review 5.  Antigens in chronic lymphocytic leukemia--implications for cell origin and leukemogenesis.

Authors:  Anders Rosén; Fiona Murray; Chamilly Evaldsson; Richard Rosenquist
Journal:  Semin Cancer Biol       Date:  2010-09-21       Impact factor: 15.707

6.  Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin.

Authors:  Charles C Chu; Rosa Catera; Lu Zhang; Sebastien Didier; Briana M Agagnina; Rajendra N Damle; Matthew S Kaufman; Jonathan E Kolitz; Steven L Allen; Kanti R Rai; Nicholas Chiorazzi
Journal:  Blood       Date:  2010-01-28       Impact factor: 22.113

7.  Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination.

Authors:  S Rutella; C Rumi; P Puggioni; T Barberi; A Di Mario; L M Larocca; G Leone
Journal:  Haematologica       Date:  1999-05       Impact factor: 9.941

8.  Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis.

Authors:  Fiona Murray; Nikos Darzentas; Anastasia Hadzidimitriou; Gerard Tobin; Myriam Boudjogra; Cristina Scielzo; Nikolaos Laoutaris; Karin Karlsson; Fanny Baran-Marzsak; Athanasios Tsaftaris; Carol Moreno; Achilles Anagnostopoulos; Federico Caligaris-Cappio; Dominique Vaur; Christos Ouzounis; Chrysoula Belessi; Paolo Ghia; Fred Davi; Richard Rosenquist; Kostas Stamatopoulos
Journal:  Blood       Date:  2007-10-24       Impact factor: 22.113

9.  Targeting B-cell anergy in chronic lymphocytic leukemia.

Authors:  Benedetta Apollonio; Cristina Scielzo; Maria Teresa Sabrina Bertilaccio; Elisa Ten Hacken; Lydia Scarfò; Pamela Ranghetti; Freda Stevenson; Graham Packham; Paolo Ghia; Marta Muzio; Federico Caligaris-Cappio
Journal:  Blood       Date:  2013-03-04       Impact factor: 22.113

10.  IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope.

Authors:  Xuchu Que; George F Widhopf; Shahzada Amir; Karsten Hartvigsen; Lotte F Hansen; Douglas Woelkers; Sotirios Tsimikas; Christoph J Binder; Thomas J Kipps; Joseph L Witztum
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

View more
  6 in total

1.  hIgD promotes human Burkitt lymphoma Daudi cell proliferation by accelerated G1/S transition via IgD receptor activity.

Authors:  Xing Dai; YuJing Wu; XiaoYi Jia; Yan Chang; HuaXun Wu; Chun Wang; HengShi Chen; WenSheng Chen; Qiong Huang; Wei Wei
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

2.  Signal-dependent and signal-independent functions of the B-cell receptor in chronic lymphocytic leukemia.

Authors:  Dimitar G Efremov; Stefania Gobessi
Journal:  Haematologica       Date:  2014-11       Impact factor: 9.941

3.  Lymphocytes eject interferogenic mitochondrial DNA webs in response to CpG and non-CpG oligodeoxynucleotides of class C.

Authors:  Björn Ingelsson; Daniel Söderberg; Tobias Strid; Anita Söderberg; Ann-Charlotte Bergh; Vesa Loitto; Kourosh Lotfi; Mårten Segelmark; Giannis Spyrou; Anders Rosén
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-02       Impact factor: 11.205

Review 4.  The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia.

Authors:  Elisa Ten Hacken; Maria Gounari; Paolo Ghia; Jan A Burger
Journal:  Leukemia       Date:  2018-12-16       Impact factor: 11.528

5.  Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL.

Authors:  Stefano Iacovelli; Eva Hug; Sara Bennardo; Marcus Duehren-von Minden; Stefania Gobessi; Andrea Rinaldi; Mirza Suljagic; Daniel Bilbao; Giulia Bolasco; Julia Eckl-Dorna; Verena Niederberger; Francesco Autore; Simona Sica; Luca Laurenti; Hongsheng Wang; Richard J Cornall; Stephen H Clarke; Carlo M Croce; Francesco Bertoni; Hassan Jumaa; Dimitar G Efremov
Journal:  Blood       Date:  2015-01-06       Impact factor: 22.113

Review 6.  The analysis of clonal expansions in normal and autoimmune B cell repertoires.

Authors:  Uri Hershberg; Eline T Luning Prak
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-05       Impact factor: 6.237

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.